Search

everythinglearnresearchcommunity

for

Search:↓

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

Certain health conditions and hair care habits affect the treatment results for a scalp condition called Central Centrifugal Cicatricial Alopecia.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

The Italian version of a relationship scale was adapted for cancer patients, showing some differences from the original and suggesting its use could improve therapy and treatment adherence.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Nurses are exposed to chemotherapy drugs, risking health issues like hair loss, so protective gear and monitoring are needed.

Patients with a specific genetic variant have more severe alopecia areata and higher recurrence rates.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

Illness perception affects mental health and quality of life in Chinese alopecia patients.

Collaborative care between physicians and pharmacists improved medication management for rheumatoid arthritis without raising costs.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

Patients with nonmelanoma skin cancers are most bothered by fear of progression, appearance concerns, and having cancer.

Transverse scalp biopsies are more accurate for diagnosing non-cicatricial alopecia, but examining both types is best for accuracy.

Systemic steroids temporarily improve severe alopecia areata in children but often lead to relapse.

Ayurvedic treatment may help manage alopecia areata.

Physicians often overlook patients' use of alternative medicine for psoriasis, highlighting a need for better communication.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

Most low-level light therapy studies did not accurately report how light was measured, affecting treatment reliability.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.